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Globally there is an increase in the number of people affected by obesity. 
This has increased the count of individuals to double, triple, and even 
quadruple. Obesity is a complex disease that has a genetic, behavioural, 
socioeconomic, and environmental effect. This raises morbidity and 
mortality in obesity. It is an important predisposition for diabetes as well 
as the current pandemic COVID-19. The rationale of this case-control 
observational study is to identify obese individuals among the diabetic and 
non-diabetic population. The study includes non - genetic factors like lipid 
profiles with genetic factors in form of SNP as a predisposition factor. The 
amplified portion of the ADIPOQ gene sequence revealed the presence of 
SNPs rs2241767 in 46.3% population and showed increased lipid profile 





Type 2 diabetes mellitus
1. Introduction 
1.1 Obesity
Obesity is a complex metabolic disorder in which there 
is an excessive amount of body fat [1]. It is an important 
predisposing factor for other health problems like diabetes 
and hypertension and vice versa [2]. Many of the diabetics 
were found to be suffering from a complication of obesity. 
The non-diabetic obese people are at high risk for diabe-
tes. This rise in the prevalence of obesity is due to eco-
nomic growth, industrialization, mechanized transport, 
urbanization. as defined by WHO Overweight and obesity 
abnormal accumulation of fat that poses a health risk. A 
body mass index (BMI) over 25 is considered overweight, 
and over 30 is obese [2]. With each year passing by over 
4 million people are dying. It has increased the global 
burden of disease in individuals as well as the healthcare 
systems now and in the future also.
1.2 Type 2 Diabetes Mellitus
It is a condition when the body not able to use the insu-
lin produced by the pancreas [2]. Type 2 Diabetes mellitus 
is common in adults and accounts for around 90% of all 
diabetes cases. It is known to lead to increased risks for 
infections. Patients with diabetes are more likely to expe-
rience severe complications from COVID-19, and those 
with poorly-controlled blood sugar are even at higher risk 
of death. Diabetes if not controlled can lead to complica-
tions like obesity.
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1.3 ADIPOQ
Adiponectin gene, responsible for the major adipocyte 
secretory protein is located on chromosome 3q27. It plays 
an important role in the metabolism of fat and the regu-
lation of glucose. Insulin sensitivity in muscle and liver 
and thereby regulates energy homeostasis and glucose tol-
erance. Obesity and diabetes are associated with low cir-
culating levels of adiponectin [3,4]. The Single Nucleotide 
Polymorphisms in ADPOQ are responsible for obesity [5].
2. Materials and methodology
2.1 Sample Collection
Following the protocol, the left-over peripheral blood 
samples were collected from 200 diabetes subjects in 
EDTA and non-EDTA vials from the subjects visiting the 
diagnostic center. They were driven for testing of Blood 
sugars and Lipid profile either with self-interest or pre-
scribed by the doctor.
2.2 Selection of Polymorphism
We limited our selection of genetic variants with SNPs 
rs2241767 [6]. in ADIPOQ.to the previously reported Sin-
gle nucleotide polymorphisms in recent epidemiological 
studies.
2.3 Selection of Biochemical Parameters 
Triglycerides, High-Density Lipoprotein (HDL), 
low-density lipoprotein (LDL), and Very low-density li-
poproteins (VLDL) are the different types of cholesterol 
present in the blood. The abnormalities in the plasma and 
blood levels of lipids are proved to be the best predictors 
of obesity. Obesity can affectively change lipid profile 
values from normal to be hypercholesterolemia, hypertri-
glyceridemia can lead to cardiovascular events [7-10].
2.4 Methodology 
Only 180 (90 cases and 90 controls) were selected for 
the study and of which only 51 Samples were processed 
for genetic study. Extraction and purification of DNA 
were done using modified Sambrook et al. protocol [11-13]. 
ADIPOQ genes with the specified target region of SNP 
associated with obesity were amplified using Polymerase 
chain reaction. The PCR amplified products were qualita-
tively checked on 1.2% agarose gel electrophoresis [14] and 
were visualized in a transilluminator after staining with 
ethidium bromide. These amplicons were then subjected 
to sequencing by the Sanger sequencing method [15]. The 
sequenced portions of the genes were checked for the con-











2.5 Analysis of Biochemical Parameters 
The mean of the lipid profile characteristics were found 
to be total cholesterol =176.8 ± 50.3 mg/dl; triglycerides 
=198.1 ± 87.7 mg/dl; HDL=42.5 ± 4.7 mg /dl and 
LDL=86.4 ± 25.8 mg/dl, VLDL=41.8 ± 20.7. The lipid 
ratios like total cholesterol/HDL=4.16 ± 10.7 cholesterol 
and the LDL cholesterol/HDL cholesterol ratio 2.0 ± 5.48. 
Table 2 shown below gives the list of the lipid profile 
characteristics of T2DM cases and Controls. 










Cholesterol 176.8±50.3 163±51.7 130-250 0.09
Triglycerides 198.1±87.7 141±56.9 50-150 0.1
HDL 42.5±4.7 43.2±5.9 35-70 0.05
LDL 86.4±25.8 44.0+28.6 Upto140 0.09
VLDL 41.8±20.7 28.6±13.6 10-40 0.09
2.6 Analysis of Variation
The SNP rs2241767 is present in T2DM 19 cases. The 
nucleotide is changed from G→T but there the corre-
sponding amino acid change showing the risk for obesity.
3. Discussion and Result
Excessive energy intake followed by lack of sufficient 
physical activity leads to increased morbidity and mor-
tality [16.17] is observed in obese people, It has become 
an economic burden on self as well as for the healthcare 
system [18-20]. Both genetic and non-genetic factors con-
tribute to the increasing prevalence of obesity [21].
Significant associations between overweight and gene 
polymorphisms of ADIPOQ were found in the diabetic 
subjects of our case-control observational study.  The 
insulin resistance also causes reduced retention of free 
DOI: https://doi.org/10.30564/jer.v2i2.2767 
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fatty acids by the adipocytes [22]
A strong influence of biochemical parameters like Lipid 
profile was observed to show the relationship with obesity. 
The presence of the above ADIPOQ gene SNPs shows the 
susceptibility to obesity. The impaired lipid profile values 
are the important predisposing factors for obesity and re-
sponsible for Type 2 Diabetes and cardiovascular disease 
in normal subjects’ controls and cases respectively. 
4. Conclusion
Obesity is the result of Cumulative effects of both ge-
netic components and biochemical parameters.
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